Skip to content

LanzaTech Global, Inc. LNZA Other accrued liabilities

Other accrued liabilities at other companies

Honeywell International logo
Honeywell InternationalHON
OPA
OPAL Fuels Inc.OPAL
XCF Global, Inc. Class A Common Stock logo
XCF Global, Inc. Class A Common StockSAFX
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND

Other financials

Income statement

See full
Revenue$12.0M+26.8%
Operating income-$9.8M+68.4%
Net income-$14.7M+23.7%
EPS (diluted)-$1.77+81.9%

Balance sheet

See full
Cash & equivalents$19.9M+23.9%
Total debt$16.3M-46.1%
Total equity$48.1M+4,194%
Total assets$105.2M-16.4%

Cash flow

See full
Operating cash flow-$9.3M+56.1%
CapEx$55.0K-92.3%
Free cash flow-$9.3M+57.3%

Valuation

See full
Market cap$75.63M-75.8%
Enterprise value$72.09M-75.1%
P/S1.3×-6.4×

Profitability

See full
Operating margin-99.2%-36.2pp
Net margin-76.1%-31.8pp
FCF margin-91.8%-29.8pp

Returns & leverage

See full
Return on equity-215.3%
Debt / equity0.3×
Current ratio-0.2×

Where this comes from

Reported directly by LanzaTech Global, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: LanzaTech Global, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about LanzaTech Global, Inc.'s other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LanzaTech Global, Inc.'s other accrued liabilities?
LanzaTech Global, Inc. (LNZA) reported other accrued liabilities of $11.14M in Q1 2026.
How has LanzaTech Global, Inc.'s other accrued liabilities changed year-over-year?
LanzaTech Global, Inc.'s other accrued liabilities increased by 48.4% year-over-year, from $7.51M to $11.14M.
What is the long-term trend for LanzaTech Global, Inc.'s other accrued liabilities?
Over 3 years (2022 to 2025), LanzaTech Global, Inc.'s other accrued liabilities has grown at a 31.7% compound annual growth rate (CAGR), from $4.5M to $10.28M.